BCL11B participates in the activation of IL2 gene expression in CD4 + T lymphocytes

Blood

Volumn 108, Issue 8, 2006, Pages 2695-2702

  Cismasiu, Valeriu B ^a   Ghanta, Sailaja ^a   Duque, Javier ^a   Albu, Diana I ^a   Chen, Hong Mei ^a   Kasturi, Rohini ^a   Avram, Dorina ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; BCL11B PROTEIN, MOUSE; DNA; DNA BINDING PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; LYMPHOCYTE ANTIGEN RECEPTOR; RECOMBINANT PROTEIN; REPRESSOR PROTEIN; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BINDING SITE; CELL ACTIVATION; GENE EXPRESSION; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CD4+ T LYMPHOCYTE; CELL CULTURE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PROMOTER REGION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 33750607751     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-05-021790     Document Type: Article

References (52)

1. Avram D, Fields A, Pretty On Top K, Nevrivy DJ, Ishmael JE, Leid M. Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J Biol Chem. 2000;275:10315-10322.
2. Avram D, Fields A, Senawong T, Topark-Ngarm A, Leid M. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. Biochem J. 2002;368:555-563.
3. Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron. 2005;45:207-221.
4. Wakabayashi Y, Watanabe H, Inoue J, et al. Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat Immunol. 2003;4:533-539.
5. Miyazawa T, Sato H, Hatakeyama K, Kitagawa T, Kominami R. Allelic losses in mouse skin tumors induced by gamma-irradiation of p53 heterozygotes. Jpn J Cancer Res. 2002;93:994-999.
6. Wakabayashi Y, Inoue J, Takahashi Y, et al. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun. 2003;301:598-603.
7. Evan GI, Littlewood TD. The role of c-myc in cell growth. Curr Opin Genet Dev. 1993;3:44-49.
8. Juin P, Hueber AO, Littlewood T, Evan G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 1999;13:1367-1381.
9. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69:119-128.
10. Bernard OA, Busson-LeConiat M, Ballerini P, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia. 2001;15:1495-1504.
11. Senawong T, Peterson VJ, Avram D, et al. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J Biol Chem. 2003;278:43041-43050.
12. Cismasiu VB, Adamo K, Gecewicz J, Duque J, Lin Q, Avram D. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. Oncogene. 2005;24:6753-6764.
13. Iwashima M. Kinetic perspectives of T cell antigen receptor signaling: a two-tier model for T cell full activation. Immunol Rev. 2003;191:196-210.
14. Hedin KE, Bell MP, Kalli KR, Huntoon CJ, Sharp BM, McKean DJ. Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NFAT/AP-1-binding promoter element. J Immunol. 1997;159:5431-5440.
15. Fraser JD, Newton ME, Weiss A. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med. 1992;175:1131-1134.
16. Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr Opin Immunol. 1995;7:333-342.
17. Serfling E, Avots A, Neumann M. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim Biophys Acta. 1995;1263:181-200.
18. Serfling E, Berberich-Siebelt F, Chuvpilo S, et al. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta. 2000;1498:1-18.
19. Chen D, Rothenberg EV. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med. 1994;179:931-942.
20. Butscher WG, Haggerty CM, Chaudhry S, Gardner K. Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells. J Biol Chem. 2001;276:27647-27656.
21. Senawong T, Peterson VJ, Leid M. BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. Arch Biochem Biophys. 2005;434:316-325.
22. Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene. 1999;236:197-208.
23. Koipally J, Heller EJ, Seavitt JR, Georgopoulos K. Unconventional potentiation of gene expression by Ikaros. J Biol Chem. 2002;277:13007-13015.
24. O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol. 2002;2:37-45.
25. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 1999;11:281-288.
26. Schimpl A, Berberich I, Kneitz B, et al. IL-2 and autoimmune disease. Cytokine Growth Factor Rev. 2002;13:369-378.
27. Loh C, Shaw KT, Carew J, et al. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem. 1996;271:10884-10891.
28. Cron RQ, Zhou B, Brunvand MW, Lewis DB. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells. Genes Immun. 2001;2:464-468.
29. Solomou EE, Juang YT, Gourley MF, Kammer GM, Tsokos GC. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol. 2001;166:4216-4222.
30. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 1994;77:727-736.
31. Lai JH, Tan TH. CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin. J Biol Chem. 1994;269:30077-30080.
32. Flescher E, Vela-Roch N, Ogawa N, et al. Abnormality of Oct-1 DNA binding in T cells from Sjogren's syndrome patients. Eur J Immunol. 1996;26:2006-2011.
33. Pan F, Ye Z, Cheng L, Liu JO. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT). J Biol Chem. 2004;279:14477-14480.
34. Decker EL, Skerka C, Zipfel PF. The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells. J Biol Chem. 1998;273:26923-26930.
35. Decker EL, Nehmann N, Kampen E, Eibel H, Zipfel PF, Skerka C. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res. 2003;31:911-921.
36. Wu J, Lingrel JB. Kruppel-like factor 2, a novel immediate-early transcriptional factor, regulates IL-2 expression in T lymphocyte activation. J Immunol. 2005;175:3060-3066.
37. Oukka M, Wein MN, Glimcher LH. Schnurri-3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells. J Exp Med. 2004;199:15-24.
38. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A. 1997;94:2927-2932.
39. Garcia-Rodriguez C, Rao A. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J Exp Med. 1998;187:2031-2036.
40. Kim TK, Maniatis T. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol Cell. 1997;1:119-129.
41. Merika M, Williams AJ, Chen G, Collins T, Thanos D. Recruitment of CBP/p300 by the IFN β enhanceosome is required for synergistic activation of transcription. Mol Cell. 1998;1:277-287.
42. Barthel R, Tsytsykova AV, Barczak AK, et al. Regulation of tumor necrosis factor α gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol Cell Biol. 2003;23:526-533.
43. Giese K, Kingsley C, Kirshner JR, Grosschedl R. Assembly and function of a TCR α enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 1995;9:995-1008.
44. Edelstein LC, Lagos L, Simmons M, Tirumalai H, Gelinas C. NF-κ B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1. Mol Cell Biol. 2003;23:2749-2761.
45. Carey M. The enhanceosome and transcriptional synergy. Cell. 1998;92:5-8.
46. Shapiro VS, Mollenauer MN, Weiss A. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP. J Immunol. 1998;161:6455-6458.
47. Butscher WG, Powers C, Olive M, Vinson C, Gardner K. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2. J Biol Chem. 1998;273:552-560.
48. Macian F, Garcia-Rodriguez C, Rao A. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 2000;19:4783-4795.
49. Lacour M, Arrighi JF, Muller KM, Carlberg C, Saurat JH, Hauser C. cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Intl Immunol. 1994;6:1333-1343.
50. Klein-Hessling S, Jha MK, Santner-Nanan B, et al. Protein kinase A regulates GATA-3-dependent activation of IL-5 gene expression in Th2 cells. J Immunol. 2003;170:2956-2961.
51. Tokoyoda K, Tsujikawa K, Matsushita H, et al. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells. Intl Immunol. 2004;16:643-653.
52. Chen CH, Zhang DH, LaPorte JM, Ray A. Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J Immunol. 2000;165:5597-5605.